S&P 500   4,008.01
DOW   32,223.42
QQQ   298.44
S&P 500   4,008.01
DOW   32,223.42
QQQ   298.44
S&P 500   4,008.01
DOW   32,223.42
QQQ   298.44
S&P 500   4,008.01
DOW   32,223.42
QQQ   298.44

Khiron Life Sciences (KHRN) Stock Forecast, Price & News

+0.02 (+11.11%)
(As of 05/16/2022 02:24 PM ET)
Today's Range
50-Day Range
52-Week Range
181,310 shs
Average Volume
220,134 shs
Market Capitalization
C$26.89 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive KHRN News and Ratings via Email

Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

About Khiron Life Sciences

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America, North America, and Europe. It operates through three segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and CBD (cannabidiol) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. is based in Vancouver, Canada.


Khiron Adds Another Clinic Location in Peru
Khiron Opens First clinic in Europe with Zerenia™ Clinics UK
See More Headlines

Industry, Sector and Symbol

Drug Manufacturers—Specialty & Generic
Year Founded

Sales & Book Value

Annual Sales
C$12.80 million
Cash Flow
C$0.05 per share
Book Value
C$0.31 per share


Pretax Margin




Free Float
Market Cap
C$26.89 million
Not Optionable

Company Calendar

Next Earnings (Estimated)


Overall MarketRank

1.60 out of 5 stars

Analyst Opinion: 2.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Khiron Life Sciences (CVE:KHRN) Frequently Asked Questions

When is Khiron Life Sciences' next earnings date?

Khiron Life Sciences is scheduled to release its next quarterly earnings announcement on Wednesday, May 25th 2022.
View our earnings forecast for Khiron Life Sciences

What price target have analysts set for KHRN?

0 brokers have issued twelve-month price targets for Khiron Life Sciences' stock. Their forecasts range from C$0.80 to C$0.80. On average, they expect Khiron Life Sciences' share price to reach C$0.80 in the next twelve months. This suggests a possible upside of 433.3% from the stock's current price.
View analysts' price targets for Khiron Life Sciences
or view top-rated stocks among Wall Street analysts.

Who are Khiron Life Sciences' key executives?
Khiron Life Sciences' management team includes the following people:
  • Dr. Alvaro Francisco Torres, Co-Founder, CEO & Director (Age 42, Pay $345.61k)
  • Mr. Swapan Kakumanu ACA, ACWA, CGA, Chief Financial Officer (Age 52)
  • Mr. Manuel Buendia, VP of Operations
  • Mr. Luis Chavez, Country Mang. of Mexico
  • Mr. Marco Algorta, Country Mang. of Uruguay
  • Ms. Franziska Katterbach, Pres of Khiron Europe
  • Mr. Juan Diego Alvarez, VP of Regulations (Age 37)
What other stocks do shareholders of Khiron Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Khiron Life Sciences investors own include Aurora Cannabis (ACB), Brookfield Property Partners (BPY), Cross Timbers Royalty Trust (CRT), Curaleaf (CURLF), Walt Disney (DIS), Energy Transfer (ET), KushCo (KSHB), Neptune Wellness Solutions (NEPT), OrganiGram (OGI) and VIVO Cannabis (VVCIF).

What is Khiron Life Sciences' stock symbol?

Khiron Life Sciences trades on the Canadian Venture Exchange (CVE) under the ticker symbol "KHRN."

How do I buy shares of Khiron Life Sciences?

Shares of KHRN and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Khiron Life Sciences' stock price today?

One share of KHRN stock can currently be purchased for approximately C$0.15.

How much money does Khiron Life Sciences make?

Khiron Life Sciences has a market capitalization of C$26.89 million and generates C$12.80 million in revenue each year.

What is Khiron Life Sciences' official website?

The official website for Khiron Life Sciences is www.khiron.ca.

How can I contact Khiron Life Sciences?

The company can be reached via phone at 705-527-3564.

This page was last updated on 5/17/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.